Cell BioEngines Secures $2M Funding from SOSV and NY Ventures
TLDR: Cell BioEngines, Inc. secures an additional $2 million in funding from SOSV and Empire State Development’s New York Ventures. The funding will support the company’s first multicenter clinical trial aimed at